Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Global prevalence of polypharmacy among the COVID-19 patients: a comprehensive systematic review and meta-analysis of observational studies
Hooman Ghasemi, Niloofar Darvishi, Nader Salari, et al.
Tropical Medicine and Health (2022) Vol. 50, Iss. 1
Open Access | Times Cited: 18

Showing 18 citing articles:

Global and regional prevalence of polypharmacy and related factors, 1997–2022: An umbrella review
Sun Young Kim, Hyeri Lee, Jaeyu Park, et al.
Archives of Gerontology and Geriatrics (2024) Vol. 124, pp. 105465-105465
Closed Access | Times Cited: 13
Prevalence of Potentially Inappropriate Prescriptions According to the New STOPP/START Criteria in Nursing Homes: A Systematic Review
Isabel Díaz Planelles, Elisabet Navarro‐Tapia, Óscar García‐Algar, et al.
Healthcare (2023) Vol. 11, Iss. 3, pp. 422-422
Open Access | Times Cited: 13
Polypharmacy and potentially inappropriate medications among hospitalized older adults with COVID-19 in Malaysian tertiary hospitals
Chee Tao Chang, Siti Mallissa Mohd Shariff, Nur Suriana Abu Bakar, et al.
Journal of Pharmaceutical Policy and Practice (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 12
Polypharmacy or potentially inappropriate medications among older adults with COVID-19 in a secondary hospital in China and their association with mortality
Mian Mao, Shan Du, Xu Yue, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Safety Aspects of Herb Interactions: Current Understanding and Future Prospects
Subhajit Hazra, Preet Amol Singh
Current Drug Metabolism (2024) Vol. 25, Iss. 1, pp. 28-53
Closed Access | Times Cited: 3
Baseline drug treatments and long-term outcomes in COVID-19-hospitalized patients: results of the 2020 AUTCOV study
Alexandra Gráf, Berthold Reichardt, Christine Wagenlechner, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Polypharmacy and the In Silico Prediction of Potential Body Proteins Targeted by These Drugs Among Hospitalized COVID-19 Patients With Cytokine Storm
Ghazwan A. M. Raouf, F. K. Mohammad, Muayad Aghali Merza
Cureus (2023)
Open Access | Times Cited: 4
Assessing medication use patterns by clinical outcomes severity among inpatients with COVID-19: A retrospective drug utilization study
Renato Ferreira‐da‐Silva, Priscila A. Maranhão, Cláudia Camila Dias, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116242-116242
Open Access | Times Cited: 1
Prevalence of Potential Drug Interactions With Direct-Acting Antivirals for COVID-19 Among Hospitalized Patients
Essy Mozaffari, Aastha Chandak, Andrew Ustianowski, et al.
Clinical Therapeutics (2024)
Open Access | Times Cited: 1
Polypharmacy in Elderly Patients: A Three-year Longitudinal Analysis in Primary Care Settings of Aragón, Spain
Priscila Matovelle, Bárbara Oliván‐Blazquez, Irene Fraile-Peñaranda, et al.
Annals of Geriatric Medicine and Research (2023) Vol. 28, Iss. 1, pp. 36-45
Open Access | Times Cited: 2
Healthcare professionals’ understanding and perception of drug-related issues linked to off-label pharmacological medications used for COVID-19
Muhammad Zeeshan Munir, Amer Hayat Khan, Tahir Mehmood Khan
Expert Review of Anti-infective Therapy (2024) Vol. 22, Iss. 6, pp. 487-493
Closed Access
Short- and Long-term Outcomes of children hospitalized with COVID-19 or Influenza: results of the AUTCOV study
Christine Wagenlechner, Ralph Wendt, Berthold Reichardt, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Baseline drug treatments and long-term outcomes in COVID- 19-hospitalized patients: results of the 2020 AUTCOV study
Alexandra Gráf, Berthold Reichardt, Christine Wagenlechner, et al.
Research Square (Research Square) (2024)
Closed Access
COVID-19 in Relation to Chronic Antihistamine Prescription
Anna Puigdellı́vol-Sánchez, Marta Juanes-González, Ana Calderón-Valdiviezo, et al.
Microorganisms (2024) Vol. 12, Iss. 12, pp. 2589-2589
Open Access
Correlates of poor clinical outcomes related to COVID-19 among older people with psychiatric illness - a mixed methods study
Surajudeen Abiola Abdulrahman, Naser Al‐Balushi, Jason Holdcroft-Long, et al.
The International Journal of Psychiatry in Medicine (2023) Vol. 58, Iss. 5, pp. 493-509
Open Access
Factores de riesgo asociados a fallecimiento por la variante ómicron de COVID-19: análisis retrospectivo con personas mayores de Canarias
Ana Hernández‐Aceituno, Eneko Larumbe‐Zabala
Revista Española de Geriatría y Gerontología (2023) Vol. 58, Iss. 4, pp. 101381-101381
Open Access
Polypharmacy and Medication Outcome Reporting Bias in Older Patients with COVID-19
Ronald B. Brown
BioMed (2023) Vol. 3, Iss. 3, pp. 320-328
Open Access
Fatores de risco para óbito e tempo de internação em pacientes com COVID-19 em uso de cloroquina e hidroxicloroquina: estudo de coorte retrospectivo
Ingred Lopes da Costa
(2023)
Open Access
Page 1

Scroll to top